You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T Cell Receptor Alpha/Beta

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

Not yet recruiting
  • Hematologic Malignancy
  • +21 more
  • (no location specified)
Feb 9, 2023

Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)

Recruiting
  • Fanconi Anemia
  • +2 more
  • Total Body Irradiation (TBI) (Plan 1)
  • +8 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 2, 2022

Pediatric Hematologic Malignancies Trial in Saint Louis (Ex Vivo T-cell receptor alpha-beta and CD19+ Depletion using CliniMACs

Not yet recruiting
  • Pediatric Hematologic Malignancies
  • Ex Vivo T-cell receptor alpha-beta and CD19+ Depletion using CliniMACs Plus
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 20, 2022

Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)

Not yet recruiting
  • Acute Lymphoblastic Leukemia in Remission
  • +10 more
  • CliniMACS
  • Houston, Texas
  • +1 more
Dec 8, 2022

T-cell Repertoire in Acute Myeloid Leukemia Undergoing Donor

Recruiting
  • Acute Myeloid Leukemia
  • Biospecimen Collection
  • Laboratory Biomarker Analysis
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 16, 2021

Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte

Active, not recruiting
  • Adult Acute Myeloid Leukemia in Remission
  • +12 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Miltenyi CliniMACS Prodigy ® system
  • (no location specified)
Mar 23, 2023

Graft Vs Host Disease, Graft-versus-host-disease Trial in San Francisco (CliniMacs®)

Recruiting
  • Graft Vs Host Disease
  • Graft-versus-host-disease
  • CliniMacs®
  • San Francisco, California
    University of California, San Francisco
Aug 2, 2022

Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

Not yet recruiting
  • Leukemia
  • +12 more
  • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
  • (no location specified)
Mar 20, 2023

Blood Disease Trial (TCRaß+/CD19+ depleted Hematopoietic stem cell (HSC) graft, CliniMACS® System)

Not yet recruiting
  • Blood Disease
  • TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
  • CliniMACS® System
  • (no location specified)
Jan 30, 2023

Hematologic Malignancies Trial in Milwaukee (CliniMACs)

Active, not recruiting
  • Hematologic Malignancies
  • CliniMACs
  • Milwaukee, Wisconsin
    Children's Hospital of Wisconsin
Apr 4, 2022

Hemoglobinopathy (Disorder), Severe Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Saint Petersburg (Haploidentical

Recruiting
  • Hemoglobinopathy (Disorder)
  • +2 more
  • Haploidentical Hematopoietic Cell Transplantation
  • Saint Petersburg, Florida
    Johns Hopkins All Children's Hospital
Sep 13, 2022

B-Cell Lymphoma, Large B-cell Lymphoma, DLBCL, Nos Genetic Subtypes Trial in New York (19(T2)28z1xx TRAC T cell)

Recruiting
  • B-Cell Lymphoma
  • +4 more
  • 19(T2)28z1xx TRAC T cell
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Feb 24, 2023

Immunodeficiencies, Immune Dysregulation Syndromes Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using CliniMACS

Recruiting
  • Immunodeficiencies
  • Immune Dysregulation Syndromes
  • Apha/beta T and CD19+ cell depletion using CliniMACS device
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Nov 8, 2022

Study of Autoimmune Lymphoproliferative Syndrome (ALPS)

Recruiting
  • Benign Lymphoproliferative Disorder
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    HER2+ Advanced Breast Cancer, Other Solid Tumors Trial (ADCC-R-Epo-R T-cells + Trastuzumab, Erythropoietin beta, Fludarabine and

    Not yet recruiting
    • HER2+ Advanced Breast Cancer
    • Other Solid Tumors
    • ADCC-R-Epo-R T-cells + Trastuzumab
    • +2 more
    • (no location specified)
    Aug 31, 2023

    CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

    Not yet recruiting
    • Lymphoma
    • Chimeric Antigen Receptor
    • (no location specified)
    Oct 24, 2023

    Leukemia, Lymphoma, Myelodysplasia Trial in Philadelphia (Alpha Beta T cell depletion)

    Recruiting
    • Leukemia
    • +2 more
    • Alpha Beta T cell depletion
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Oct 27, 2021

    Non-hodgkin Lymphoma,B Cell Trial in Beijing (Autologous CD19-STAR-T cell, Fludarabine, Cyclophosphamide)

    Recruiting
    • Non-hodgkin Lymphoma,B Cell
    • Autologous CD19-STAR-T cell
    • +2 more
    • Beijing, Beijing, China
    • +1 more
    Nov 21, 2022

    Diabetes Trial in Vienna, Paris (68Ga-NODAGA-exendin-4 PET/CT)

    Recruiting
    • Diabetes Mellitus
    • 68Ga-NODAGA-exendin-4 PET/CT
    • Vienna, Austria
    • +1 more
    Jun 16, 2022

    Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial

    Not yet recruiting
    • Recurrent B Acute Lymphoblastic Leukemia
    • +5 more
    • Interferon Beta-1A
    • +10 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 6, 2023

    Kidney Transplant, Kidney Failure, Highly Sensitized Trial in Boston, New York, Philadelphia (Cyclophosphamide, CART-BCMA,

    Not yet recruiting
    • Kidney Transplant
    • +2 more
    • Boston, Massachusetts
    • +2 more
    Sep 20, 2023

    Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • KYV-101 anti-CD19 CAR-T cell therapy
    • Standard lymphodepletion regimen
    • Palo Alto, California
      Stanford Multiple Sclerosis Center
    Nov 13, 2023

    Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV Trial in Denver,

    Recruiting
    • Lupus Nephritis
    • +2 more
    • KYV-101 anti-CD19 CAR-T cell therapy
    • Standard lymphodepletion regimen
    • Denver, Colorado
    • +1 more
    Jul 7, 2023

    Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

    Not yet recruiting
    • Prostate Carcinoma
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 17, 2023